Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,408,511
-
Share change
-
+1,644,473
-
Total reported value
-
$1,178,204,417
-
Put/Call ratio
-
112%
-
Price per share
-
$41.46
-
Number of holders
-
172
-
Value change
-
+$55,478,700
-
Number of buys
-
78
-
Number of sells
-
98
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q3 2020
As of 30 Sep 2020 INTERCEPT PHARMACEUTICALS IN - COM (ICPT) had 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,408,511 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FIRST TRUST ADVISORS LP, JPMORGAN CHASE & CO, Sarissa Capital Management LP, BOXER CAPITAL, LLC, AMERIPRISE FINANCIAL INC, and Senvest Management, LLC.
This table shows 172 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.